Morgan Stanley resumed coverage of Aviva after the Direct Line deal

Morgan Stanley has resumed coverage of Aviva (LON:AV) with an "overweight" rating and a 680p price target, following its strategic acquisition of Direct Line which significantly expands its UK general insurance presence and is projected to boost capital-light earnings to over 70% by 2026-2027. The firm forecasts approximately 15% annualised EPS growth through 2027, a 12% free cash flow yield, and a 6.4% dividend yield, positioning Aviva as its preferred domestic UK insurance pick despite a solvency ratio that, while below peers, remains above internal targets and is forecast to improve to 206% by 2027.

Analysis

Morgan Stanley has resumed coverage of Aviva with a new 'overweight' rating and a 680p price target, signaling over 10% upside from its last close. The bullish stance is fundamentally driven by the completed acquisition of Direct Line, a transaction that establishes Aviva as a top-three player in most of its UK operating segments and strategically shifts its earnings profile to be more capital-light. The brokerage forecasts that over 70% of Aviva's earnings will be capital-light by 2026-2027, enhancing its comparability with larger European multi-line peers. This strategic shift is expected to fuel significant growth, with Morgan Stanley projecting an annualized EPS growth of approximately 15% through 2027, and operating profit more than doubling from £1.47 billion in 2023 to £2.91 billion by 2027. The financial outlook is further supported by a compelling shareholder return proposition, including a projected 12% free cash flow yield by 2027—significantly above the 8% average for peers—and a 6.4% dividend yield. The primary point of caution noted is Aviva's relatively weaker solvency ratio compared to peers, though it is forecast to improve to 206% by 2027 and remains above the company's internal targets.

Key Decisions for Investors

• Investors should consider Aviva as a core holding in the UK insurance sector, given the 'overweight' rating, strong EPS growth forecasts, and a total shareholder return potential of approximately 18% highlighted by Morgan Stanley.
• The successful integration of Direct Line is the central catalyst for the investment thesis; therefore, it is crucial to monitor quarterly reports for synergy realization and progress on improving the combined operating ratio to the targeted 89.4%.
• While the growth and yield story is attractive, investors must closely track the solvency ratio, as its progression towards the forecasted 206% by 2027 is a key factor in mitigating balance sheet risk relative to peers.